PLX3397 is an oral tyrosine kinase inhibitor of CSF1R in macrophages, that was able to attenuate the negative effects of inflammation in several chronic conditions including fatty liver, obesity, diabetes and even cancer in preclinical studies36. This evidence concerns the gene CSF1R and diabetes mellitus.